$Boxlight (BOXL.US)$ The earnings report is pretty bad compared to other years.. so expect a increase in the price because the stock market is retarded.
2
Report
8 Seconds
:
There is nothing wrong with those numbers. They beat estimates on both revenues and losses. What's bad about the earnings report?
The consensus update that leads to the downgrade of the revenue forecasts and an increase in losses per share for Boxlight has led to a shift in sentiment among analysts, which could make investors wary of the company.
Boxlight Stock Forum
The earnings report is pretty bad compared to other years.. so expect a increase in the price because the stock market is retarded.
$Grove Collaborative (GROV.US)$ 16m float / 74% institutional/ 30% CTB
$Acorda Therapeutics (ACOR.US)$ 1.2m float/ 18% institutional/ 37% CTB
$Verastem (VSTM.US)$ 16m float / 40% institutional/ 18% CTB
$Cibus Inc (CBUS.US)$ 16m float / 12% institutional
$Bone Biologics (BBLG.US)$ 27m float / 17% institutional/ 127% CTB
$Greenlane (GNLN.US)$ 1.5m float/ 17% institutional/ 35% CTB
$VistaGen Therapeutics (VTGN.US)$ 7.2m floa...
No comment yet